Search

The Business Times

Biotech

Singapore

Singapore biotech startup Nanyang Biologics bets on AI drug discovery platform to unlock revenue

Compared with other industries, biotech startups typically have long and uncertain timelines, as well as high capital requirements – all of which translate into perceived higher risk.
Singapore

Challenging economic conditions raise the bar for nascent biotech startups as funding dries up

The impact of Trump’s pharma tariffs on drugmakers is evident, but the upstream implications for start-ups developing novel drugs are less clear.
Singapore

Singapore draws international biotech VCs as Asia-Pacific life sciences sector takes off

China has accounted for over 75% of regional venture capital and private equity funding since 2019, and now contributes 26.7% of all drugs in the global development pipeline – up from 23.6% the year before, says Bain & Company.
Global Enterprise

China’s biotech boom: Collaboration, not competition, for Singapore

Less-than-favourable valuations for biopharma companies may be a key reason behind the lack of such companies listing on the SGX.
Singapore

The biopharma scene in Singapore is vibrant, but few make it to SGX

Hong Kong’s benchmark Hang Seng Index has surged 30 per cent this year, doubling gains in China’s CSI 300 Index.
Capital Markets & Currencies

Hong Kong stock ETFs get record China money on AI, biotech craze

The Hong Kong-listed company did not declare any dividend for the six month period, unchanged from the year before.
Companies & Markets

A*Star biotech spin-off Mirxes trims losses to US$28.4 million as top line grows

Mirxes said it expects its addition to the index will significantly increase the company’s visibility and trading liquidity.
Companies & Markets

Singapore-headquartered Mirxes to join Alibaba, Tencent on Hang Seng Composite Index

Seqirus will list on the Australian securities exchange by the end of this fiscal year.
Consumer & Healthcare

Australian biotech giant CSL to spin off vaccine unit Seqirus, cut 15% of workforce

FILE PHOTO: Boxes of Ozempic and Wegovy made by Novo Nordisk are seen at a pharmacy in London, Britain March 8, 2024. REUTERS/Hollie Adams/File Photo
Companies & Markets

Singapore’s KPB Biosciences fails in bid to unfreeze assets in US$830 million Novo Nordisk legal battle

Latest T-bills Treasury Bills Results & Interest NewsLatest SSB Singapore Savings Bonds NewsLatest COE Certificate of Entitlement News
Latest Johor-Singapore SEZ NewsLatest BTO Build To Order & Sales of Balance NewsLatest STI Straits Times Index NewsLatest SGX Dividends, Share Price NewsLatest Bonds Market NewsLatest Singapore Stocks To Buy NewsLatest Singapore Economy News
View More
Credit Suisse Share Price, Dividends & NewsUBS Share Price, Dividends & NewsUOB Share Price, Dividends & News
DBS Share Price, Dividends & NewsOCBC Share Price, Dividends & NewsGreat Eastern Share Price, Dividends & NewsCiti, Citigroup Share Price, Dividends & NewsMalaysian Ringgit Rates & NewsJapanese Yen Rates & NewsUS Dollar Rates & News
View More
Sembcorp Share Price NewsSeatrium Share Price NewsSheng Siong Share Price News
99 Group Share Price NewsCapitaLand Share Price NewsST Engineering Share Price NewsSingtel Share Price NewsSIA Singapore Airlines Share Price NewsKeppel Corp Share Price NewsGenting Singapore Share Price News
View More
CPF Central Provident Fund NewsMAS Monetary Authority of Singapore NewsInland Revenue Authority of Singapore News
MOF Ministry of Finance Singapore NewsSingapore Budget NewsSingapore Elections NewsSingapore Manufacturing NewsSingapore Inflation Rate NewsGST Goods & Services Tax NewsCDC Vouchers News
View More
Keppel Pacific Oak US REIT NewsKeppel DC REIT NewsCapitaland Integrated Commercial Trust CICT REIT News
Mapletree Industrial Trust REIT NewsCapitaland Ascendas REIT NewsDigital Core REIT NewsFrasers Logistics & Commercial Trust REIT NewsMapletree Logistics Trust REIT NewsMapletree Pan Asia Commercial Trust REIT NewsFrasers Centrepoint Trust REIT News
View More
Singapore ABSD NewsSingapore Rental Market NewsGCB Good Class Bungalow News
SLA Singapore Land Authority NewsCDL City Developments Limited NewsLanded Property NewsChina Property NewsResidential Property NewsCommercial & Industrial Property NewsHDB Resale Flats and Housing News
View More
The Business Times
News
Breaking NewsPropertyResidentialCommercial & IndustrialSingaporeInternationalStartups & TechOpinion & FeaturesESGWorking Life
Companies
Companies & MarketsBanking & FinanceReits & PropertyEnergy & CommoditiesTelcos, Media & TechTransport & LogisticsConsumer & HealthcareCapital Markets & Currencies
Wealth
WealthWealth & InvestingPersonal FinanceCrypto & Alternative AssetsSupplements
Living
LifestyleFood & DrinkMotoringStyle & TravelWatchesArts & DesignBT Luxe
More
E-paperVideosNewslettersPodcastsPersonal SubscriptionGroup SubscriptionPaid Press ReleaseAdvertise with UsEvents & Awards
bt recommends
thriveTech in AsiaAsean BusinessGlobal EnterpriseSGSME
Mobile
Download on the Apple StoreDownload on the Google Play Store
  • about us
  • contact us
  • help
  • privacy policy
  • terms & conditions
  • cookie policy
  • data protection policy

MDDI (P) 046/10/2024. Published by SPH Media Limited, Co. Regn. No. 202120748H. Copyright © 2025 SPH Media Limited. All rights reserved.

2.41.9